Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(12)
•••
Ekenbullets
X
View Profile
View Bullboard History
Post by
Ekenbullets
on Feb 07, 2022 12:30pm
A deal is a deal is a deal?
So while we wait for the DEAL, lets here some thoughts on it. All seem to agree (even Charly and metalsguy!) that a deal is needed to move the sp. But a deal can look a thousand ways and range from
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Feb 04, 2022 12:11am
RE:What's wrong with this picture???
The analyst report has been out for a couple days. The target is 2.50 and the current price is 1.60. I'd be happy if douggy was right with his price. Sva needs all the analysts it can get to pick
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(24)
•••
steadfast
X
View Profile
View Bullboard History
Post by
steadfast
on Feb 03, 2022 10:52pm
What's wrong with this picture???
After getting hammered, SVA was gaining momentum, opening higher 4 days in a row. Doug Loe puts out Analyst Report. Stock opens lower. Someone does not want SVA to gain Momentum. Who
...more
(28)
•••
satchmo6
X
View Profile
View Bullboard History
Post by
satchmo6
on Feb 03, 2022 9:28pm
waiting to sell something
in order to buy a good position----Leede has been a good informer.
(2)
•••
Treesh
X
View Profile
View Bullboard History
Post by
Treesh
on Feb 03, 2022 6:22pm
Sernova has a 59 per cent upside, says Leede Jones Gable
Douglas Loe of Leede Jones Gable is standing pat with Sernova (Sernova Stock Quote, Chart, News, Analysts, Financials TSXV:SVA), maintaining a “Speculative Buy” rating and target price of
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Feb 03, 2022 1:02pm
RE:RE:ViaCyte CEO interview
Spill needs to take a page from Shap-heros getting shite done book. Shap-hero already bombed his first clinical but woo'd the world anyways and now going in for round 2 with his new Extra McCRISPR
...more
(73)
•••
Sailboatdream
X
View Profile
View Bullboard History
Comment by
Sailboatdream
on Feb 03, 2022 8:44am
RE:ViaCyte CEO interview
Yep... race is on! And we have someone in the rear view mirror closing in with their own pouch. Is SVA squandering its lead in quest of the "perfect" deal? MY
...more
(12)
•••
Ekenbullets
X
View Profile
View Bullboard History
Post by
Ekenbullets
on Feb 03, 2022 5:29am
ViaCyte CEO interview
https://www.technologynetworks.com/tn/blog/gene-edited-stem-cell-derived-therapies-a-functional-cure-for-t1d-357837?
(12)
•••
Ekenbullets
X
View Profile
View Bullboard History
Post by
Ekenbullets
on Feb 03, 2022 5:22am
ViaCyte first patient dosed. Race is on.
ViaCyte yesterday announced the first patient has been dosed in the Phase 1 clinical trial of VCTX210 for the treatment of type 1 diabetes (T1D). VCTX210 is an investigational, allogeneic, gene
...more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on Feb 03, 2022 12:13am
RE:To Sonny & the longs
It amazes you how some people think this happens overnight???? 88 4 years is not overnight. While it can take anywhere from 6 to 12 years to get a new drug through final approval. In the USA, the FDA
...more
(21)
•••
88STR8T
X
View Profile
View Bullboard History
Post by
88STR8T
on Feb 02, 2022 9:12pm
To Sonny & the longs
Hello, I am dropping by to say I miss Sonny as well. I also miss all of the longs that were here during that period when Sonny was here. The past year on this board has been a real disappointment as
...more
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on Feb 02, 2022 12:21pm
RE:Juicy bid @ 1.7
If they don't already have a large position it would be the wrong way. But if you have a large position and have the confidence, nothing wrong with pressing your bet.
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on Feb 02, 2022 10:32am
Juicy bid @ 1.7
Hmm, if I sink that bid will I be able to buy back. If they are actually looking to buy 300k, they are going about it the wrong way...
(413)
•••
woundedknee
X
View Profile
View Bullboard History
Comment by
woundedknee
on Feb 02, 2022 9:20am
RE:Sonny
Yes, I still have kept a couple of his PMs and think of him quite often.
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >